Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)

SHA:605199 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 29, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	4,965	6,066	6,410	9,971	9,651	-
Market Cap Growth	-6.32%	-5.37%	-35.71%	3.32%	-	-
Enterprise Value	6,091	7,039	6,749	10,111	9,721	-
Last Close Price	12.41	14.97	15.82	24.60	23.69	-
PE Ratio	42.64	56.96	74.81	138.22	79.43	-
PS Ratio	2.67	3.18	4.23	7.37	8.31	-
PB Ratio	4.15	5.23	6.31	10.72	10.53	-
P/TBV Ratio	5.16	6.40	7.03	12.25	12.19	-
P/OCF Ratio	63.41	214.70	26.85	97.29	2924.53	-
EV/Sales Ratio	3.27	3.70	4.45	7.47	8.37	-
EV/EBITDA Ratio	36.01	38.71	46.94	86.08	67.48	-
EV/EBIT Ratio	56.93	54.06	69.20	139.08	96.68	-
Debt / Equity Ratio	1.11	1.11	0.67	0.54	0.31	0.26
Debt / EBITDA Ratio	7.83	6.80	4.60	4.13	1.96	1.05
Debt / FCF Ratio	-	-	-	-	-	1.98
Asset Turnover	0.65	0.71	0.74	0.83	0.89	1.20
Inventory Turnover	2.51	3.79	3.02	2.74	2.64	3.12
Quick Ratio	0.69	1.03	0.89	1.07	1.40	0.97
Current Ratio	1.06	1.33	1.18	1.37	1.76	1.37
Return on Equity (ROE)	9.99%	10.36%	8.71%	7.53%	15.57%	19.28%
Return on Assets (ROA)	2.32%	3.03%	2.99%	2.77%	4.82%	6.96%
Return on Capital (ROIC)	2.80%	3.93%	3.90%	3.46%	6.24%	9.71%
Return on Capital Employed (ROCE)	5.70%	6.60%	7.80%	7.50%	10.30%	17.60%
Earnings Yield	2.24%	1.76%	1.34%	0.72%	1.26%	-
FCF Yield	-3.03%	-7.60%	-2.40%	-0.35%	-0.58%	-
Dividend Yield	1.01%	0.83%	-	-	0.63%	-
Payout Ratio	83.48%	29.64%	16.75%	102.23%	6.58%	71.14%
Buyback Yield / Dilution	7.74%	3.33%	-1.81%	-5.55%	-4.13%	-12.43%
Total Shareholder Return	8.74%	4.16%	-1.81%	-5.55%	-3.50%	-12.43%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.